Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision tag on the page updated from v3.5.3 to v3.5.4, indicating an updated build of the document or interface assets.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated to v3.5.3, indicating a newer version of the page. This reflects a minor update to the page’s versioning rather than a substantive change to study details.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page’s revision/version label was updated from v3.5.0 to v3.5.2. This does not change the study content displayed.SummaryDifference0.0%

- Check68 days agoChange DetectedSite revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check104 days agoChange DetectedThe update is a minor revision from v3.4.1 to v3.4.2 with no visible user-facing changes to the study details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.